Retrospective study to assess incidence and predictors of opioid abuse overdose and death associated with opioid overdose among patients prescribed opioid products in long-term use.
The purpose of this study is to quantify risk, and predictors of risks for opioid overdose and for death associated with opioid overdose in persons who are or have been long-term recipients of prescriptions for Schedule II opioids. The study uses coded terms in large heath databases maintained by healthcare providers and health insurers, supplemented by overdose deaths identified from the National Death Index. The terms for overdose are combined following validated rules as developed in companion studies. The study is being conducted in parallel with a prospective questionnaire-based cohort study of the same risks.
Study Type
OBSERVATIONAL
Enrollment
808,455
No intervention.
HealthCore Inc
Wilmington, Delaware, United States
Optum
Boston, Massachusetts, United States
Kaiser Permanente Northwest
Portland, Oregon, United States
Vanderbilt University
Nashville, Tennessee, United States
Opioid overdose - fatal and nonfatal
Opioid overdose as identified in insurance claims, electronic medical records and National Death Index records.
Time frame: Retrospective review over period from October 1, 2006 to December 31, 2017
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.